Japanese Entertainment Stock News

TSE:3397
TSE:3397Hospitality

A Look At TORIDOLL Holdings (TSE:3397) Valuation As Franco Manca Faces UK Restructuring

UK restructuring move puts Franco Manca under the spotlight TORIDOLL Holdings (TSE:3397) has called a board meeting for April 16, 2026, to consider starting a UK restructuring process for Franco Manca 2 UK Limited, the operator of its Fulham group pizza chain. See our latest analysis for TORIDOLL Holdings. The restructuring news comes as TORIDOLL Holdings trades at ¥4,108, with a 30 day share price return decline of 5.84% and a 1 year total shareholder return decline of 4.33%. However, the 5...
TSE:3350
TSE:3350Hospitality

Is Metaplanet (TSE:3350) Offering Value After Recent Crypto Sentiment Swings?

If you are wondering whether Metaplanet is attractively priced or already reflecting high expectations, the current share price raises some important questions about value and risk. At a last close of ¥328, the stock has seen a 3.2% decline over the past week, a 7.9% gain over the past month, a 29.9% year to date decline, and a 4.7% decline over the past year. Its 3 year return is very large and its 5 year return is almost 5x. Recent coverage around Metaplanet has focused on its role as a...
TSE:6857
TSE:6857Semiconductor

Advantest (TSE:6857) Margin Surge To 33.3% Reinforces Bullish AI Testing Narrative

Advantest (TSE:6857) closed out FY 2026 with fourth quarter revenue of ¥328.1 billion and basic EPS of ¥174.81, backed by trailing twelve month revenue of ¥1.1 trillion and EPS of ¥515.15 that sits alongside 132.9% earnings growth and a net profit margin of 33.3% over the last year. Over recent periods, the company has seen quarterly revenue move from ¥232.3 billion in Q4 FY 2025 to ¥328.1 billion in Q4 FY 2026, while quarterly basic EPS has shifted from ¥54.47 to ¥174.81. This feeds into the...
TSE:6762
TSE:6762Electronic

Is It Too Late To Consider TDK (TSE:6762) After Its 1 Year 86.7% Surge?

Wondering if TDK is still attractively priced after a strong run, or if most of the easy gains are already on the table. TDK's share price recently closed at ¥2,681.5, with returns of 4.1% over 7 days, 27.1% over 30 days, 19.2% year to date and 86.7% over 1 year, and very large gains over 3 and 5 years of 189.0% and 197.1% respectively. Recent coverage has focused on how TDK fits into broader themes in electronics and technology hardware, with investors watching how demand trends and capital...
TSE:6501
TSE:6501Industrials

Hitachi (TSE:6501) Margin Improvement To 7.6% Tests Concerns Over Premium 28.2x P/E

Hitachi (TSE:6501) has wrapped up FY 2026 with fourth quarter revenue of ¥3.1t and basic EPS of ¥36.08, set against trailing twelve month revenue of ¥10.6t and EPS of ¥176.76 that follows reported earnings growth of 30.3% over the past year. Over recent periods the company has seen quarterly revenue move from ¥2.5t and EPS of ¥30.20 in FY 2025 Q3 to ¥2.8t and EPS of ¥40.20 in FY 2025 Q4, reaching ¥3.1t and EPS of ¥36.08 in FY 2026 Q4. This positions you to focus on how a 7.6% net profit...
TSE:4503
TSE:4503Pharmaceuticals

Astellas Pharma (TSE:4503) Margin Surge To 13.6% Tests Bearish Earnings Narratives

Astellas Pharma (TSE:4503) has laid out its FY 2026 scorecard with second half revenue of ¥1.1t and basic EPS of ¥80.33, alongside net income excluding extraordinary items of ¥143.9b. The company has seen revenue move from ¥976.7b and basic EPS of ¥12.72 in the second half of FY 2025, to ¥1.0t and ¥82.44 in the first half of FY 2026, before reaching ¥1.1t and ¥80.33 in the latest period. Over the same timeframe, trailing twelve month EPS has increased from ¥28.35 to ¥162.77. For investors,...
TSE:5332
TSE:5332Building

Is It Too Late To Consider TOTO (TSE:5332) After Its 59.9% One-Year Rally?

If you are wondering whether TOTO is priced attractively right now, the key question is how its current share price compares with its underlying worth. The stock last closed at JP¥5,421, and its returns over 1 year sit at 59.9%, with 23.6% year to date, 27.9% over 3 years, 6.6% over 5 years, 0.7% over 7 days, and a 0.1% decline over 30 days, which can change how investors think about both opportunity and risk. Recent news coverage has focused on TOTO in the context of broader market interest...
TSE:8984
TSE:8984REITs

Assessing Daiwa House REIT Investment (TSE:8984) Valuation After Half Year Earnings Release

Earnings release puts Daiwa House REIT Investment (TSE:8984) in focus Daiwa House REIT Investment (TSE:8984) has moved into the spotlight after reporting half year results to February 28, 2026, including revenue of ¥32,063.37 million and net income of ¥12,213.07 million. See our latest analysis for Daiwa House REIT Investment. At a share price of ¥127,400, Daiwa House REIT Investment has a year to date share price return of an 11.10% decline, yet its 1 year total shareholder return of 12.65%...
TSE:8750
TSE:8750Insurance

Is It Time To Reassess Daiichi Life Group (TSE:8750) After Japan Governance Reforms?

If you are wondering whether Daiichi Life Group's current share price reflects its underlying value, this article walks through what the numbers are really saying about the stock. The share price most recently closed at ¥1,410.5, with returns of 5.7% year to date and 48.6% over 1 year. Meanwhile, the 7 day and 30 day returns of a 3.4% decline and a 1.9% decline hint at a more mixed short term picture. Recent coverage has focused on Daiichi Life Group's role within the Japanese insurance...
TSE:6645
TSE:6645Electronic

Is It Too Late To Consider OMRON (TSE:6645) After Its Recent Share Price Rebound?

If you are wondering whether OMRON is priced attractively right now, the recent share performance and a mixed valuation picture make it a stock worth a closer look. The share price closed at ¥5,093, with returns of 1.9% over 7 days, 13.0% over 30 days, 27.5% year to date and 21.5% over 1 year. This compares with declines of 31.8% over 3 years and 33.1% over 5 years. Recent news around OMRON has focused on the company as a key name in Japan's technology sector. This helps frame how investors...
TSE:4307
TSE:4307IT

Nomura Research Institute (TSE:4307) Q4 EPS Loss Challenges Bullish Margin Recovery Narratives

Latest FY 2026 Results Snapshot Nomura Research Institute (TSE:4307) has just capped FY 2026 with fourth quarter revenue of ¥212.4b and a basic EPS loss of ¥118.43, a sharp contrast to the trailing twelve month EPS of ¥26.62 and net income of ¥15.3b. Over the past several quarters, revenue has moved from ¥196.6b in Q4 FY 2025 to ¥195.8b, ¥201.3b and ¥205.3b, before reaching ¥212.4b in Q4 FY 2026. Quarterly basic EPS shifted from ¥38.40 to ¥45.43, ¥48.09 and ¥51.68, ahead of the latest...
TSE:6954
TSE:6954Machinery

Fanuc (TSE:6954) Margin Strength And 12.9% Earnings Growth Test Valuation Concerns

Fanuc (TSE:6954) closed out FY 2026 with fourth quarter revenue of ¥234.5b and basic EPS of ¥53.24, set against trailing 12 month revenue of ¥857.8b and EPS of ¥178.47. Earnings over the past year improved 12.9% with forecasts pointing to about 7.4% annual growth. Over recent periods the company has seen quarterly revenue move from ¥197.1b in FY 2025 Q3 to ¥234.5b in FY 2026 Q4, with basic EPS over those same quarters ranging from ¥35.21 to ¥53.24. Trailing net margin held at 19.4% versus...
TSE:6723
TSE:6723Semiconductor

Renesas Electronics (TSE:6723) Q1 Profit Rebound Tests Bearish Unprofitability Narrative

Renesas Electronics (TSE:6723) opened Q1 2026 with revenue of ¥380.3 billion and basic EPS of ¥37.57, while trailing twelve month EPS sits at a loss of ¥5.31, underlining that the latest quarterly profit is set against a still-unprofitable year. The company has seen quarterly revenue move from ¥292.6 billion in Q4 2024 to ¥380.3 billion in Q1 2026, with basic EPS ranging from a loss of ¥33.38 in Q2 2025 to ¥58.66 in Q3 2025. Investors are watching how consistently these margins can hold up...
TSE:8604
TSE:8604Capital Markets

Nomura Holdings (TSE:8604) Margin Slippage Tests Long Running Earnings Growth Narrative

Nomura Holdings (TSE:8604) has wrapped up FY 2026 with fourth quarter revenue of ¥577.2b and basic EPS of ¥25.29, setting the tone for how investors assess the latest earnings run. Over recent periods, revenue has moved from ¥452.7b in FY 2025 Q4 to ¥577.2b in FY 2026 Q4, while quarterly basic EPS shifted from ¥24.35 to ¥25.29. On a trailing twelve month basis, EPS and net income reached ¥123.08 and ¥362.1b respectively, supported by revenue of ¥2.17t. With a trailing net margin of 16.7%...
TSE:5423
TSE:5423Metals and Mining

Tokyo Steel Manufacturing (TSE:5423) Margin Decline Reinforces Bearish Narratives On Earnings Quality

Tokyo Steel Manufacturing (TSE:5423) has wrapped up FY 2026 with fourth quarter revenue of ¥66.2b and basic EPS of ¥21.05, setting the tone for a year where trailing twelve month revenue came in at ¥268.1b and EPS at ¥112.55. Over recent periods the company has seen quarterly revenue move from ¥80.4b and EPS of ¥66.02 in FY 2025 Q3 to ¥73.1b and EPS of ¥36.18 in FY 2026 Q1, before settling at FY 2026 Q4 levels. This frames a year where investors are likely to focus on how thinner margins and...
TSE:4519
TSE:4519Pharmaceuticals

Chugai Pharmaceutical (TSE:4519) Q1 Net Margin Near 35% Reinforces Bullish Profitability Narratives

Chugai Pharmaceutical (TSE:4519) opened 2026 with Q1 revenue of ¥321,747 million and basic EPS of ¥70.13, setting the tone off the back of a year where trailing twelve month revenue reached about ¥1.29 trillion and EPS came in at ¥274.77. Over recent quarters the company has seen revenue move from ¥288,459 million and EPS of ¥59.09 in Q1 2025 to ¥346,301 million and EPS of ¥78.04 in Q4 2025, giving you a clear view of the top line and per share earnings trend heading into the latest print...
TSE:3407
TSE:3407Chemicals

Asahi Kasei Expands Pharma Reach With Aicuris Deal And AK1940 Trial

Asahi Kasei (TSE:3407) has completed its acquisition of German biopharmaceutical company Aicuris Anti-infective Cures. The company has also initiated a Phase I clinical trial for AK1940, a new therapy candidate for autoimmune diseases. Both developments mark a shift in focus toward infectious and autoimmune disease treatments within Asahi Kasei's pharmaceutical operations. Asahi Kasei, traditionally known for chemicals, materials, and health care businesses, is steadily building out its...
TSE:7912
TSE:7912Commercial Services

How Investors May Respond To Dai Nippon Printing (TSE:7912) Expanding Its Advanced Automotive Display Films

Dai Nippon Printing Co., Ltd. has announced it will begin mass production in April 2026 of a new decorative film for automotive displays that combines woodgrain-style design with advanced optical performance, initially targeting the Chinese market before moving into Europe, Japan, the United States, South Korea, India and other regions. An interesting angle is DNP’s plan to apply this microfabricated, Electron Beam-coated film beyond car interiors, including exterior auto components and...